Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Cristofanilli

Showing results (111-120 of 438) with videos related to

Pageof 44
Sort By:
Cancer|May 23, 2012
The use of bevacizumab among women with metastatic breast cancer: a survey on clinical practice and the ongoing controversyShaheenah Dawood, Asim Jamal Shaikh, Thomas A Buchholz, et al.
International Journal of Clinical Oncology|January 7, 2011
Chromosome 17 polysomy in circulating tumor cells in patients with metastatic breast cancer: a case seriesNaoki Hayashi, Seigo Nakamura, Hiroshi Yagata, et al.
Clinical Breast Cancer|March 17, 2004
Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experienceMassimo Cristofanilli, Ana Maria Gonzalez-Angulo, Aman U Buzdar, et al.
Clinical Breast Cancer|October 3, 2013
A comparison of epidemiology, biology, and prognosis of inflammatory breast cancer in Japanese and US populationsAkina Natori, Naoki Hayashi, Kumiko Soejima, et al.
Journal of Experimental Therapeutics & Oncology|February 21, 2009
Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cellsFredika M Robertson, Ann-Marie Simeone, Abhijit Mazumdar, et al.
Breast Cancer Research and Treatment|March 9, 2017
Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patientsCatherine Bingham, Sandra V Fernandez, Patricia Fittipaldi, et al.
Breast Cancer Research : BCR|May 23, 2022
CCR5 activation and endocytosis in circulating tumor-derived cells isolated from the blood of breast cancer patients provide information about clinical outcomeAshvathi Raghavakaimal, Massimo Cristofanilli, Cha-Mei Tang, et al.
International Review of Cell and Molecular Biology|April 18, 2024
Inflammatory breast cancer: Epidemiologic data and therapeutic resultsHamouda Boussen, Yosra Berrazaga, Sherif Kullab, et al.
Cancer Chemotherapy and Pharmacology|March 27, 2002
Lack of activity of stealth liposomal doxorubicin in the treatment of patients with anthracycline-resistant breast cancerEdgardo Rivera, Vicente Valero, Francisco J Esteva, et al.
Molecular Cancer Research : MCR|August 18, 2018
Impeding Circulating Tumor Cell Reseeding Decelerates Metastatic Progression and Potentiates ChemotherapyChen Qian, Asurayya Worrede-Mahdi, Fei Shen, et al.
Pageof 44

Showing results (111-120 of 438) with videos related to

Sort By:
Pageof 44
Cancer|May 23, 2012
The use of bevacizumab among women with metastatic breast cancer: a survey on clinical practice and the ongoing controversyShaheenah Dawood, Asim Jamal Shaikh, Thomas A Buchholz, et al.
International Journal of Clinical Oncology|January 7, 2011
Chromosome 17 polysomy in circulating tumor cells in patients with metastatic breast cancer: a case seriesNaoki Hayashi, Seigo Nakamura, Hiroshi Yagata, et al.
Clinical Breast Cancer|March 17, 2004
Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experienceMassimo Cristofanilli, Ana Maria Gonzalez-Angulo, Aman U Buzdar, et al.
Clinical Breast Cancer|October 3, 2013
A comparison of epidemiology, biology, and prognosis of inflammatory breast cancer in Japanese and US populationsAkina Natori, Naoki Hayashi, Kumiko Soejima, et al.
Journal of Experimental Therapeutics & Oncology|February 21, 2009
Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cellsFredika M Robertson, Ann-Marie Simeone, Abhijit Mazumdar, et al.
Breast Cancer Research and Treatment|March 9, 2017
Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patientsCatherine Bingham, Sandra V Fernandez, Patricia Fittipaldi, et al.
Breast Cancer Research : BCR|May 23, 2022
CCR5 activation and endocytosis in circulating tumor-derived cells isolated from the blood of breast cancer patients provide information about clinical outcomeAshvathi Raghavakaimal, Massimo Cristofanilli, Cha-Mei Tang, et al.
International Review of Cell and Molecular Biology|April 18, 2024
Inflammatory breast cancer: Epidemiologic data and therapeutic resultsHamouda Boussen, Yosra Berrazaga, Sherif Kullab, et al.
Cancer Chemotherapy and Pharmacology|March 27, 2002
Lack of activity of stealth liposomal doxorubicin in the treatment of patients with anthracycline-resistant breast cancerEdgardo Rivera, Vicente Valero, Francisco J Esteva, et al.
Molecular Cancer Research : MCR|August 18, 2018
Impeding Circulating Tumor Cell Reseeding Decelerates Metastatic Progression and Potentiates ChemotherapyChen Qian, Asurayya Worrede-Mahdi, Fei Shen, et al.
Pageof 44